Our Company

JensonR+ is a technical consultancy with a simple mission; we aim to promote better health through simplifying the journey from innovation to the marketplace.
We achieve this through offering wide-ranging services to cover the full product life-cycle, from concept through to launch and beyond.

Our specialist team is experienced in regulatory affairs, product development, quality assurance, drug safety, medical information, copy approval, project management, training and market access. We can provide support at all levels, from strategy through to administration, which allows us to tailor our services to meet your specific needs as your company moves from innovation and development to the market place.

JensonR+ was formed in 2011, through a joint venture with the regulatory consultancy, Dr Regenold GmbH. Our clients range from small innovators and entrepreneurs, through to Blue Chip corporations, and come from the human and veterinary pharmaceutical, cosmetics, foods, devices, herbals and legal industries.

After the referendum which resulted in the decision for the UK to leave the European Union, and with UK exit negotiations underway, it became apparent that there was a large degree of uncertainty of what the post Brexit landscape would look like. JensonR+ prides itself on being a professional and adaptable organisation, this ensures we deliver consistently high levels of service, support and successes. As part of our continuing commitment to all our clients, existing and new, in 2017 we announced the opening of our Ireland based office to ensure we can continue to provide our clients with our full service offering. We believe that this proactive attitude to Brexit will help protect your brands, equity and help you build strategic blueprints.

Meet Our Team

Sarah Ware
Sarah WareChief Executive Officer
Nicola Hardman
Nicola HardmanDirector
James Hall
James HallDirector
Sue Gandy
Sue GandyQPPV & Pharmacovigilance Manager
Mandy Jeffery
Mandy JefferyScientific Manager
Marilyn Brown
Marilyn BrownMedical Information Officer
Lisa Courtier
Lisa CourtierPharmacovigilance Officer
David Lough
David LoughPharmacovigilance Officer
Sue Lakeman
Sue LakemanSenior Regulatory Officer
Neil Prideaux
Neil PrideauxRegulatory Manager
Janet Worrell
Janet WorrellRegulatory Manager
Melanie Joy
Melanie JoySenior Regulatory Officer
Joanne Lokes
Joanne LokesSenior Regulatory Officer
Chloe Child
Chloe ChildRegulatory Officer and Responsible Person
Sarah Pender
Sarah PenderQualified Person for Pharmacovigilance
Paul Quinn
Paul QuinnQualified Person
Lisa White
Lisa WhiteRegulatory Officer
Matthew Burton
Matthew BurtonResponsible Person & Technical Manager
Rebecca Liversedge
Rebecca LiversedgeQuality Assurance Manager
Shane Sankey
Shane SankeyFinance Manager
Rebekah Gladstone
Rebekah GladstoneFinance Officer
Susan Child
Susan ChildScientific Officer
Jo Biederman
Jo BiedermanAdministrative Officer
Lydia Gladstone
Lydia GladstoneCompliance Officer
Claire CreweQuality Officer
Helen SeurindQPPV & Senior Pharmacovigilance Officer
Anthony ChapmanResponsible Person & Technical Manager

Consultants

Formerly the CEO of JensonR+, one of our company founders, currently a Director and a Board member, Martin has a long history of drug development and provision of strategic advice.

One of our Board members and an expert in business development, market access, portfolio-management, including due diligence and licensing, and product supply processes. Jutta is also the Managing Director of Dr. Regenold GmbH.

A pharmaceutical physican with fifteen years’ experience of drug development and commercialisation.

A practising physician with 20 plus years’ experience in medical and clinical functions, gained within diverse companies ranging from large multinationals to SMEs. Duncan has worked with people from a wide range of roles as well as with NICE, public health and policy advisory committees, and academia.

A pharmaceutical marketer in the UK and Ireland with over 25 years’ experience in all aspects of marketing, Linda supports JensonR+ with product launch plans, including pricing and reimbursement, and in promotional compliance.

Graham has a wealth of QA and QC experience gained across  pharmaceuticals and medical devices. Graham currently assists JensonR+ providing support on clients QMS activities and training in QMS principles

regulanet

JensonR+ Limited is a lead member of the international regulatory network regulanet®

regulanet® is a group of highly skilled, experienced, like minded individuals and their companies, who have come together to offer a complete healthcare development service. Together, we form a network with representation in over 90 countries throughout the world. The services we offer span all aspects of product development, from brand and company strategy, product formulation and development, packaging development and implementation, extensive clinical, medical and regulatory expertise coupled with technology sourcing, product licensing and world class project management capabilities.

Founded in 2001 by Dr. Regenold GmbH, regulanet® offers services to a wide variety of national and international healthcare and pharmaceutical clients. The members of the network provide advice and assistance on national and international projects and marketing authorisation procedures, including the decentralised, mutual recognition and centralised procedures within Europe.

Our clients can utilise all of the resources that regulanet® can offer, or just access a specific part of our capabilities. Whatever your requirements, a project leader will provide a single point of contact and coordinate all project activity across the network.

Over the years the services offered by members have been expanded and now include all aspects of development, regulatory and market access in their respective countries.

A technical consultancy with a simple mission

We aim to promote better health through simplifying the journey from innovation to the marketplace.

Contact Us